Development of sustained release gastro-retentive tablet formulation of nicardipine hydrochloride using quality by design (QbD) approach

The objective of the present study was to develop a sustained release gastro-retentive (SRGR) tablet formulation of nicardipine hydrochloride (HCl) for once-a-day dosing using the quality by design (QbD) approach. The quality target product profile of nicardipine HCl SRGR tablet formulation was defined, and critical quality attributes (CQAs) were identified. Potential risk factors were identified using a fish bone diagram and failure mode effect analysis (FMEA) tool and screened by the Plackett–Burman design, and finally nicardipine HCl SRGR tablet formulation was optimized using the Box–Behnken design. The tablets were prepared by a direct compression technique using polymers such as hydroxypropylmethylcellulose (HPMC K15M), glyceryl behenate, alone or in combinations and other standard excipients. Sodium bicarbonate was incorporated as a gas-generating agent. The effects of polymers and sodium bicarbonate on the drug release profile and floating properties were investigated as these parameters are likely to affect the desired once-a-day dosing regimen and finally the therapeutic efficacy of SRGR drug delivery systems. It was observed that formulation variables X₁: Glyceryl behenate (mg/tab) and X₂: HPMC K15M (mg/tab) strikingly influenced the drug release (%) (Y₁), whereas floating lag time (min) (Y₂) was significantly impacted by the formulation variable X₃: Sodium bicarbonate (mg/tab). A design space plot within which the CQAs remained unchanged was established at a lab scale. In conclusion, this study demonstrated the suitability of a glyceryl behenate-HPMC K15M polymer combination along with sodium bicarbonate to achieve SRGR tablet formulation for once-a-day dosing of nicardipine HCl using the systematic QbD approach.     

Nanosuspension of efavirenz for improved oral bioavailability: formulation optimization,in vitro,in situ and in vivo evaluation

Context: Nanosuspensions (NSs) of poorly water-soluble drugs are known to increase the oral bioavailability.

Objectives: The purpose of this study was to develop NS of efavirenz (EFV) and to investigate its potential in enhancing the oral bioavailability of EFV.

Materials and methods: EFV NS was prepared using the media milling technique. The Box–Behnken design was used for optimization of the factors affecting EFV NS. Sodium lauryl sulfate and PVP K30 were used to stabilize the NS. Freeze-dried NS was completely re-dispersed with double-distilled filtered water.

Results: Mean particle size and zeta potential of the optimized NS were found to be 320.4?±?3.62?nm and –32.8?±?0.4 mV, respectively. X-ray diffraction and differential scanning calorimetric analysis indicated no phase transitions. Rate and extent of drug dissolution in the dissolution medium for NS was significantly higher compared to marketed formulation. The parallel artificial membrane permeability assay revealed that NS successfully enhanced the permeation of EFV. Results of in situ absorption studies showed a significant difference in absorption parameters such as K_a, t_1/2 and uptake percentages between lyophilized NS and marketed formulation of EFV. Oral bioavailability of EFV in rabbits resulting from NS was increased by 2.19-fold compared to the marketed formulation.

Conclusion: Thus, it can be concluded that NS formulation of EFV can provide improved oral bioavailability due to enhanced solubility, dissolution velocity, permeability and hence absorption.     

In situ forming implants for the delivery of metronidazole to periodontal pockets: formulation and drug release studies

This study was performed to obtain prolonged drug release with biodegradable in situ forming implants for the local delivery of metronidazole to periodontal pockets. The effect of polymer type (capped and uncapped PLGA), solvent type (water-miscible and water-immiscible) and the polymer/drug ratio on in vitro drug release studies were investigated. In situ implants with sustained metronidazole release and low initial burst consisted of capped PLGA and N-methyl-2-pyrolidone as solvent. Mucoadhesive polymers were incorporated into the in situ implants in order to modify the properties of the delivery systems towards longer residence times in vivo. Addition of the polymers changed the adhesiveness and increased the viscosity and drug release of the formulations. However, sustained drug release over 10 days was achievable. Biodegradable in situ forming implants are therefore an attractive delivery system to achieve prolonged release of metronidazole at periodontal therapy.     

Process,optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease

The major challenge involved in the treatment of inflammatory bowel disease is targeted delivery of the drug at the site of inflammation. As nanoparticles possess the ability to accumulate at the site of inflammation, present investigation aims at development of Budesonide-loaded nanostructured lipid carrier systems (BDS-NLCs) for the treatment of inflammatory bowel disease. BDS-NLCs were prepared by employing a high pressure homogenization technique. Various preliminary trials were performed for optimization of the NLCs in which different processes, as well as formulation parameters, were studied. The BDS-NLCs was optimized statistically by applying a 3-factor/3-level Box–Behnken design. Drug concentration, surfactant concentration, and emulsifier concentration were selected as independent variables, and % entrapment efficiency and particle size were selected as dependent variables. The best batch comprises of 10%, 7%, and 20% w/w concentration of drug, surfactant, and emulsifier, respectively, with % entrapment efficiency of 92.66?±?3.42% and particle size of 284.0?±?4.53?nm. Further, in order to achieve effective delivery of nanoparticulate system to colonic region, the developed BDS-NLCs were encapsulated in Eudragit^® S100-coated pellets. The drug release studies of pellets depict intactness of BDS-NLCs during palletization process, with f₂ value of 75.879. The in vitro evaluation of enteric-coated pellets revealed that a coating level of 15% weight gain is needed in order to impart lag time of 5?h (transit time to reach colon). The results of the study demonstrate that the developed BDS-NLCs could be used as a promising tool for the treatment of inflammatory bowel disease.     

Beneficiation of low-grade iron ore fines by multi-gravity separator (MGS) using optimization studies

There is an urgent need for development of environmental friendly processes through which iron ore fines can be beneficiated and utilized effectively. For processing of low-grade iron ores, ground to finer size necessitates the use of centrifugal force. This is because the settling rate of the particles in centrifugal force is 500–600 times more than that noticed for the nominal gravitational force. Multi-gravity separator (MGS) is the one such unit used for recovering hematitic fines without addition of chemicals. In the present article, an approach has been made to beneficiate low-grade hematitic iron ore of Jilling mine, Odisha, India, using MGS. The effect of three important variables was studied and their influences were analyzed through statistical approach to optimize grade, recovery, and separation efficiency. Use of response surface methodology (RSM) based on Box–Behnken design has also been adopted for analysis purpose. The results obtained indicate that it is possible to beneficiate low-grade hematitic iron ore from a feed of 50.74% Fe to 65.11% Fe with an acceptable recovery of 71.88%. Optimization of process variables was done for each response, optimized independently irrespective of other responses. Further optimization of the variables was carried out with a multi-objective target.     

Optimization of reagent dosages with the use of response surface methodology and evaluation of test results with upgrading curves in graphite flotation

The aim of this study is to reduce reagent consumptions in graphite flotation with the addition of Aero 3477 promoter to the flotation stage. A three-level Box–Behnken design is used for optimization and modeling of flotation stages. For this purpose, the flotation experiments are performed in two steps. The maximum weight recovery and the minimum ash content values of the rougher concentrate are calculated as 21.41 and 32.49% using diesel oil dosage (714.24?g/t), methyl isobutyl carbinol (MIBC) dosage (212.81?g/t), and sodium silicate (Na₂SiO₃) dosage (1451.189?g/t), respectively, in the preliminary experiment tests. Subsequently, keeping the Na₂SiO₃ dosage constant, Aero 3477 promoter is added to the flotation stage to provide reduction at reagent consumptions. As a result, the reagent consumptions of diesel oil dosage (162.10?g/t), MIBC dosage (129.58?g/t), and Aero 3477 promoter dosage (168.96?g/t) are supplied to reach the approximate weight recovery and the ash content as in primary experimental results. Considerable dosage decreases in both diesel oil and MIBC are achieved using promoter. Moreover, experimental studies are also evaluated using upgrading curves.     

Formulation,optimization, and characterization of rifampicin-loaded solid lipid nanoparticles for the treatment of tuberculosis

Abstract

Mycobacterium tuberculosis, being the causative infectious agent, is the leading cause of death worldwide amongst the infectious disease. The low bioavailability of rifampicin (RIF), one of the vital constituent of antitubercular therapy, instigates an urge to develop nanocarrier, which can prevent its degradation in the acidic pH of the stomach. Solid lipid nanoparticles (SLNs) have been proven to be promising versatile platform for oral delivery of lipophilic drugs. Therefore, the current investigation demonstrates development of RIF-loaded solid lipid nanoparticles (RIF-SLNs) using high-pressure homogenization technique by employing a three-level, three-factor Box–Behnken design. Concentration of drug, concentration of emulsifier, and homogenization pressure were selected as an independent variables, and %drug loading (%DL), %entrapment efficiency (%EE), and particle size were selected as dependent variables. The developed RIF-SLNs were characterized for particle size, polydispersity index, zeta potential, %EE, %DL, differential scanning calorimetry, X-ray diffraction, and TEM analysis. The mean diameter of RIF-SLNs was found to be 456?±?11?nm, %EE of 84.12?±?2.78%, and %DL of 15.68?±?1.52%. The in vitro lipolysis experiments revealed that RIF-SLNs stabilized using poloxamer 188, exhibited antilipolytic effect. Furthermore, the in vitro GI stability studies (at pH 1.2, pH 4.5, pH 6.8, and pH 7.4) revealed that the developed system could withstand various gastrointestinal tract media. The in vitro dissolution studies depicted biphasic drug release profile for drug-loaded SLNs revealing best fit with Weibull model. The accelerated stability studies for 6?months does not revealed any significant change in characteristics of developed RIF-SLNs.     

Improved initial burst of estradiol organogel as long-term in situ drug delivery implant: formulation,in vitro and in vivo characterization

Objective: The present investigation was aimed at optimizing of estradiol (E2) loaded l-amino acid derivatives organogel formulations resulting in improved the high initial release problems and sustained release of E2.

Methods: The visco-elastic properties of blank organogels were measured by rheometer. The E2 organogel formulations were optimized using a central composite design. Also, the effect of gelator structure and composition of the gel formulations on release behavior (in vitro and in vivo) had been studied.

Results: The change of the gelator structure could affect significantly the stiffness of the implants. The release behavior of gel without N-Methyl-2-pyrrolidinone (NMP) was controlled by gel corrosion only. While the drug release of the gel with NMP was controlled by both corrosion and diffusion. The high initial release problems of the organogels were improved by optimizing the formulations. The system consisting by N-Lauroyl l-lysine methyl ester (LLM) derivative in the oil indicated the lowest initial drug release, showed a much lower blood drug level and maintained a steady state for nearly 1 month.

Conclusion: Organogels based on l-lysine methyl ester derivative were ideal carriers for long-term parenteral administration of E2.     

正交设计法研究聚酰胺酸分子量及其影响因素

采用正交试验设计方法,研究了聚酰胺酸固体含量、反应温度、加料间隔时间和反应时间对聚酰胺酸分子量的影响,采用凝胶渗透色谱仪测试了不同反应条件下合成的聚酰胺酸的分子量。正交设计试验结果表明,合成最高分子量聚酰胺酸的反应条件为:反应温度为15℃,固体含量为8%,加料间隔时间为9min,反应时间为3h。在此基础上,使用TGA测试了由不同分子量聚酰胺酸合成的聚酰亚胺薄膜的热稳定性。试验结果显示,聚酰胺酸分子量越大,薄膜的热稳定性越好。     

Development and in vitro evaluation of pH-independent release matrix tablet of weakly acidic drug valsartan using quality by design tools

Abstract

The main objective of this study was the development of pH-independent controlled release valsartan matrix tablet in Quality by design (QbD) framework. The quality target product profile (QTPP), critical quality attributes (CQAs) and critical material attributes (CMAs) were defined by science and risk-based methodologies. Potential risk factors were identified with Fishbone diagram. Following, CMAs were further investigated with a semi-quantitative risk assessment method, which has been revised with mitigated risks after development and optimization studies. According to defined critical material attributes, which one of them was determined to be the dissolution, formulation optimization study was performed by using a statistical design of experiment. Formulation variables have been identified and fixed first with a ‘One factor at a time (OFAT)’ approach. After OFAT studies, a statistical experimental design was conducted with the most critical material attributes. Statistical design space and mathematical prediction equations have been developed for dissolution and hardness, which is important to predict drug dissolution behavior. In conclusion, a pH-independent release has been achieved for weakly acidic drug valsartan with a deeper understanding of drug product quality, with the science and risk-based approaches of QbD tools.     

Design and evaluation of mucoadhesive microemulsion for neuroprotective effect of ibuprofen following intranasal route in the MPTP mice model

Background: The present study is to investigate the neuroprotective effect of ibuprofen by intranasal administration of mucoadhesive microemulsion (MMEI) against inflammation-mediated by dopaminergic neurodegeneration in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson’s disease (PD).

Methods: Ibuprofen-loaded polycarbophil-based MMEI was developed by using response surface methodology (RSM). Ibuprofen with dose of 2.86 mg/kg/day was administered intranasally to male C57BL/6 mice for two consecutive weeks which were pre-treated with four intraperitoneal injections of MPTP (20?mg/kg of body weight) at 2?h intervals. Immunohistochemistry was performed.

Results: Optimal MMEI was stable and non-ciliotoxic with 66.29?±?4.15?nm as average globule size and??20.9?±?3.98?mV as zeta potential. PDI value and transmission electron microscopy result showed the narrow globule size distribution of MMEI. The result showed that all three independent variables had a significant effect (p?<?0.05) on the responses. Rota-rod and open-field test findings revealed the significant improvement in motor performance and gross behavioral activity of the mice. The results from in vivo study and immunohistochemistry showed that nasal administration of Ibuprofen significantly reduced the MPTP-mediated dopamine depletion. Furthermore TH neurons count in the substantia nigra and the density of striatal dopaminergic nerve terminals were found to be significant higher for ibuprofen treated groups.

Conclusion: Findings of the investigation revealed that Ibuprofen through developed MMEI was shown to protect neurons against MPTP-induced injury in the Substantia nigra pars compacta (SNpc) and striatum and hence, could be a promising approach for brain targeting of Ibuprofen through intranasal route to treat PD.     

Reliability-based robust design optimization of gap size of annular nuclear fuels using kriging and inverse distance weighting methods

In this study, the design optimization of the gap size of annular nuclear fuels used in pressurized water reactors (PWRs) was performed. For this, thermoelastic–plasticity–creep (TEPC) analysis of PWR annular fuels was carried out using an in-house code to investigate the performance of nuclear fuels. Surrogate models based on the kriging and inverse distance weighting models were generated using computational performance data based on optimal Latin hypercube design. Using these surrogate models, the gap size of PWR annular fuel was deterministically optimized using the micro-genetic algorithm to improve the heat transfer efficiency and maintain a lower level of stress. Reliability-based design optimization and reliability-based robust design optimization were conducted to satisfy target reliability and secure the robustness of the PWRs’ performance. The optimal gap size was validated through TEPC analysis and the optimum solutions were compared according to the approximate method and reliability index.     

High refractive index films of ZnS/PVP nanocomposite by in situ thermolysis

A simple and rapid process for deposition of high refractive index films of ZnS/PVP nanocomposite (NC) is described. Precursor films are dip-coated on glass/quartz substrates from methanolic solution of polyvinylpyrrolidone (PVP) containing Zn⁺²–thiourea (TU) complex. ZnS/PVP nanocomposite films are produced by heating the solid precursor at 200°C for 10 min in air. Heat treatment converts the Zn⁺²–TU complex to ZnS by thermolysis in situ PVP. The transmission spectra of the films (typically 700 nm thickness) in the wavelength range of 200–1000 nm showed an absorption edge near 300 nm due to ZnS nanoparticles and high transmission of 97% beyond 400 nm. ZnS nanoparticles are uniformly dispersed in PVP matrix having sizes of about 3–4 nm. For ZnS loading of 45% by weight, the refractive index of ZnS/PVP is 1.65 which is in between that of PVP (1.48) and ZnS (2.36). Fourier Transform Infrared (FTIR) spectroscopy of the composite showed that there is a strong interaction between ZnS nanocrystals and PVP. The root mean square (RMS) roughness of the films is about 3 nm as determined by atomic force microscope (AFM).     

微粒群算法在自动控制系统设计中的应用

提出了将微粒群优化(Particle Swarm Optimization,PSO)算法与控制系统设计相结合的系统设计思路和方法。系统设计过程包括两个部分：首先基于历史输入输出数据,用微粒群算法建立系统的模型,然后基于得到的模型进行控制器的设计,并用微粒群算法进行控制器的参数优化整定。仿真试验结果表明,微粒群算法在控制系统设计的模型建立、控制器参数优化等方面发挥了重要的作用,简化了控制系统设计任务,提高了设计效率。     

Formulation and development of ophthalmic in situ gel for the treatment ocular inflammation and infection using application of quality by design concept

Context: The conventional liquid ophthalmic delivery systems exhibit short pre-corneal residence time and the relative impermeability to the cornea which leads to poor ocular bioavailability.

Objective: The aim of this study was to apply quality by design (QbD) for development of dexamethasone sodium phosphate (DSP) and tobramycin sulfate (TS)-loaded thermoresponsive ophthalmic in situ gel containing Poloxamer 407 and hydroxyl propyl methyl cellulose (HPMC) K4M for prolonging the pre-corneal residence time, ocular bioavability and decreases the frequency of administration of dosage form. The material attributes and the critical quality attributes (CQA) of the in situ gel were identified. Central composite design (CCD) was adopted to optimize the formulation.

Materials and methods: The ophthalmic in situ forming gels were prepared by cold method. Materials attributes were the amount of Poloxamer 407 and HPMC and CQA identified were Gel strength, mucoadhesive index, gelation temperature and % of drug release of both drug.

Results and discussion: Optimized batch (F*) containing 16.75% poloxamer 407 and 0.54% HPMC K4M were exhibited all results in acceptable limits. Compared with the marketed formulation, optimized in situ gel showed delayed T_max, improved C_max and AUC in rabbit aqueous humor, suggesting the sustained drug release and better corneal penetration and absorption.

Conclusion: According to the study, it could be concluded that DSP and TS would be successfully formulated as in situ gelling mucoadhesive system for the treatment of steroid responsive eye infections with the properties of sustained drug release, prolonged ocular retention and improved corneal penetration.     

Integrating failure analysis and risk analysis with quality assurance in the design phase of medical product development

Today, manufacturing operates as a global network, which has created more awareness of the quality of products and services. A systematic and rational way of managing quality assurance is currently lacking. This can cause serious problems in sectors such as the medical industry, as product failure may not only cause time delays, but also create risks for the health and safety of patients and users. This paper proposes a quality assurance approach that incorporates risk analysis (based on ISO14971) and failure analysis (based on FMEA) into the product design phase to assure product quality in the short term and facilitate global manufacturing practices in the long run. The proposed approach includes a Markov model to predict product failure from a customer perspective, which serves as a checkpoint for feedback to provide a basis for quality assurance. A medical equipment firm is used as a test-bed to illustrate how the proposed approach works and to verify its effectiveness.     

Taguchi-based design of experiments in training POD-RBF surrogate model for inverse material modelling using nanoindentation

This paper investigates the use of a surrogate model based on Proper Orthogonal Decomposition (POD) and Radial Basis Functions (RBF) for calibrating the nanoindentation-based loading of an elastic–plastic material. Using Taguchi design of experiments and Analysis of Variance (ANOVA), the total number of finite element-based training points is reduced for input parameters that exhibited lower significance. It is found that ANOVA-based sensitivity information can be used to reduce the number of training points without significantly affecting model accuracy. It is also observed that RBFs capable of conforming nonlinearly perform better when the spatial distance between training points increases. Furthermore, for some RBFs the performance is further tuned by choice of the shape parameters. Finally, it is demonstrated that the surrogate model’s performance remains stable under the effect of random noise. Thereby, this study provides a general framework for solving a nanoindentation-based material modelling inverse problem using the POD–RBF technique.